AptaBio Therapeutics Inc. (KOSDAQ: 293780)
South Korea
· Delayed Price · Currency is KRW
6,310.00
-100.00 (-1.56%)
Nov 15, 2024, 9:00 AM KST
AptaBio Therapeutics Revenue
AptaBio Therapeutics had revenue of 1.12B KRW in the quarter ending June 30, 2024, with 16,414.26% growth. This brings the company's revenue in the last twelve months to 2.06B. In the year 2023, AptaBio Therapeutics had annual revenue of 323.87M with 569.80% growth.
Revenue (ttm)
2.06B
Revenue Growth
+569.80%
P/S Ratio
68.79
Revenue / Employee
n/a
Employees
n/a
Market Cap
156.79B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 323.87M | 275.52M | 569.80% |
Dec 31, 2022 | 48.35M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition